219 related articles for article (PubMed ID: 30108120)
1. Severe thromboembolic phenomenon in the setting of pseudoprogression of melanoma brain metastases in response to combination immunotherapy.
Perez MC; Yu HM; Markowitz J
BMJ Case Rep; 2018 Aug; 2018():. PubMed ID: 30108120
[TBL] [Abstract][Full Text] [Related]
2. Unmasking of intracranial metastatic melanoma during ipilimumab/nivolumab therapy: case report and literature review.
McDonald MA; Sanghvi P; Bykowski J; Daniels GA
BMC Cancer; 2018 May; 18(1):549. PubMed ID: 29743050
[TBL] [Abstract][Full Text] [Related]
3. Site-specific response patterns, pseudoprogression, and acquired resistance in patients with melanoma treated with ipilimumab combined with anti-PD-1 therapy.
Pires da Silva I; Lo S; Quek C; Gonzalez M; Carlino MS; Long GV; Menzies AM
Cancer; 2020 Jan; 126(1):86-97. PubMed ID: 31584722
[TBL] [Abstract][Full Text] [Related]
4. Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study.
Long GV; Atkinson V; Lo S; Sandhu S; Guminski AD; Brown MP; Wilmott JS; Edwards J; Gonzalez M; Scolyer RA; Menzies AM; McArthur GA
Lancet Oncol; 2018 May; 19(5):672-681. PubMed ID: 29602646
[TBL] [Abstract][Full Text] [Related]
5. Metastatic uveal melanoma showing durable response to anti-CTLA-4 and anti-PD-1 combination therapy after experiencing progression on anti-PD-1 therapy alone.
Afzal MZ; Mabaera R; Shirai K
J Immunother Cancer; 2018 Feb; 6(1):13. PubMed ID: 29433557
[TBL] [Abstract][Full Text] [Related]
6. Lung brain metastasis pseudoprogression after nivolumab and ipilimumab combination treatment.
Melian M; Lorente D; Aparici F; Juan O
Thorac Cancer; 2018 Dec; 9(12):1770-1773. PubMed ID: 30276979
[TBL] [Abstract][Full Text] [Related]
7. Complete intracranial response to talimogene laherparepvec (T-Vec), pembrolizumab and whole brain radiotherapy in a patient with melanoma brain metastases refractory to dual checkpoint-inhibition.
Blake Z; Marks DK; Gartrell RD; Hart T; Horton P; Cheng SK; Taback B; Horst BA; Saenger YM
J Immunother Cancer; 2018 Apr; 6(1):25. PubMed ID: 29622046
[TBL] [Abstract][Full Text] [Related]
8. The forgotten role of adjuvant immune checkpoint inhibitors in preventing melanoma brain metastasis.
El Rassy E; Farhat F; Kattan J
Immunotherapy; 2018 Nov; 10(15):1289-1291. PubMed ID: 30474477
[No Abstract] [Full Text] [Related]
9. Metastatic primary pulmonary melanoma successfully treated with checkpoint inhibitors.
Al-Helou G; Temesgen N; Gwizdala J; Ahari J
BMJ Case Rep; 2018 Mar; 2018():. PubMed ID: 29545428
[TBL] [Abstract][Full Text] [Related]
10. Real-world efficacy and toxicity of combined nivolumab and ipilimumab in patients with metastatic melanoma.
Parakh S; Randhawa M; Nguyen B; Warburton L; Hussain MA; Cebon J; Millward M; Yip D; Ali S
Asia Pac J Clin Oncol; 2019 Feb; 15(1):26-30. PubMed ID: 30426665
[TBL] [Abstract][Full Text] [Related]
11. Serial pseudoprogression of metastatic malignant melanoma in a patient treated with nivolumab: a case report.
Ozaki Y; Shindoh J; Miura Y; Nakajima H; Oki R; Uchiyama M; Masuda J; Kinowaki K; Kondoh C; Tanabe Y; Tanaka T; Haruta S; Ueno M; Kitano S; Fujii T; Udagawa H; Takano T
BMC Cancer; 2017 Nov; 17(1):778. PubMed ID: 29162045
[TBL] [Abstract][Full Text] [Related]
12. Pseudoprogression of Melanoma Brain Metastases.
Simard JL; Smith M; Chandra S
Curr Oncol Rep; 2018 Nov; 20(11):91. PubMed ID: 30413981
[TBL] [Abstract][Full Text] [Related]
13. Two heads better than one? Ipilimumab immunotherapy and radiation therapy for melanoma brain metastases.
Patel KR; Lawson DH; Kudchadkar RR; Carthon BC; Oliver DE; Okwan-Duodu D; Ahmed R; Khan MK
Neuro Oncol; 2015 Oct; 17(10):1312-21. PubMed ID: 26014049
[TBL] [Abstract][Full Text] [Related]
14. Health-related quality of life in patients with melanoma brain metastases treated with immunotherapy.
Thompson JR; Lai-Kwon J; Morton RL; Guminski AD; Gonzalez M; Atkinson V; Sandhu S; Brown MP; Menzies AM; McArthur GA; Lo SN; Long GV; Bartula I
Immunotherapy; 2023 Jun; 15(8):593-610. PubMed ID: 37132182
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: evaluation of brain control and toxicity.
Minniti G; Anzellini D; Reverberi C; Cappellini GCA; Marchetti L; Bianciardi F; Bozzao A; Osti M; Gentile PC; Esposito V
J Immunother Cancer; 2019 Apr; 7(1):102. PubMed ID: 30975225
[TBL] [Abstract][Full Text] [Related]
16. Intracranial antitumor responses of nivolumab and ipilimumab: a pharmacodynamic and pharmacokinetic perspective, a scoping systematic review.
van Bussel MTJ; Beijnen JH; Brandsma D
BMC Cancer; 2019 May; 19(1):519. PubMed ID: 31146733
[TBL] [Abstract][Full Text] [Related]
17. Nivolumab and ipilimumab: immunotherapy for treatment of malignant melanoma.
Carreau NA; Pavlick AC
Future Oncol; 2019 Feb; 15(4):349-358. PubMed ID: 30334646
[TBL] [Abstract][Full Text] [Related]
18. Cohort versus patient level simulation for the economic evaluation of single versus combination immuno-oncology therapies in metastatic melanoma.
Gibson EJ; Begum N; Koblbauer I; Dranitsaris G; Liew D; McEwan P; Yuan Y; Juarez-Garcia A; Tyas D; Pritchard C
J Med Econ; 2019 Jun; 22(6):531-544. PubMed ID: 30638416
[No Abstract] [Full Text] [Related]
19. Paraneoplastic acral vascular syndrome in a patient with metastatic melanoma under immune checkpoint blockade.
Gambichler T; Strutzmann S; Tannapfel A; Susok L
BMC Cancer; 2017 May; 17(1):327. PubMed ID: 28499411
[TBL] [Abstract][Full Text] [Related]
20. Melanoma Brain Metastasis Pseudoprogression after Pembrolizumab Treatment.
Cohen JV; Alomari AK; Vortmeyer AO; Jilaveanu LB; Goldberg SB; Mahajan A; Chiang VL; Kluger HM
Cancer Immunol Res; 2016 Mar; 4(3):179-82. PubMed ID: 26701266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
